secwatch.observer — SEC 8-K summary
======================================

Issuer:     Chemours Co (CC)
CIK:        0001627223
Form:       8-K
Filed at:   2023-04-27T23:59:59+00:00
Accession:  0000950170-23-015291
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Chemours Q1 2023 net sales $1.5B, adj EBITDA $304M; reaffirms FY guidance
-------------------------------------------------------------------------

- Net sales $1.5B, down 13% YoY; Net income $145M, EPS $0.96; Adjusted EPS $0.98, down 33%.
- Adjusted EBITDA $304M, down 25% YoY; TSS segment record results on Opteon demand; TT mixed.
- Board approved Q2 dividend of $0.25 per share, unchanged from prior quarter.
- Appointed Denise Dignam President, TT & Chemical Solutions; Gerardo Familiar President, APM.
- Reaffirming full-year 2023 Adjusted EBITDA and Free Cash Flow guidance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1627223/000095017023015291/0000950170-23-015291-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1627223/000095017023015291/cc-20230427.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-015291

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer